Reckitt Benkiser (Bangladesh) Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reckitt Benkiser (Bangladesh) Ltd with three other
pharmaceutical manufacturers in Asia:
Nang Kuang Pharmaceutical Co Ltd
of TAIWAN
(2020
sales of 1.75 billion Taiwanese Dollars [US$63.28 million]
of which 92%
was Western medicine),
Highnoon Laboratories Limited
of PAKISTAN
(10.70 billion Pakistan Rupees [US$63.12 million]
), and
Tianda Pharmaceuticals Ltd
which is
based in HONG KONG
(491.48 million Hong Kong Dollars [US$63.13 million]
of which 90%
was Pharmaceutical and Biotechnology Busines).
Sales Analysis.
During the second
quarter of 2021, sales at Reckitt Benkiser (Bangladesh) Ltd totalled
1.23 billion Bangladeshi Taka.
This is a drop of 11.2%
from the 1.38 billion Bangladeshi Taka in sales at the company during the second quarter in 2020.
During the first two
quarters of 2021, sales totalled 2.51 billion Bangladeshi Taka, which is
3.0% lower
than through the first two quarters of 2020.
Reckitt Benkiser (Bangladesh) Ltd reported sales of 5.33 billion Bangladeshi Taka (US$62.67 million)
for the
year ending
December of 2020.
This
represents
an
increase of 29.3%
versus 2019, when the company's sales were 4.13 billion Bangladeshi Taka.
Sales at Reckitt Benkiser (Bangladesh) Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 85%).